Celerion

Tempe, Arizona 85289

0 studies enrolling now · 122 studies all time

What they study most

Acromegaly, Alzheimer Disease, Alzheimer's Disease, Amyloid Cardiomyopathy, Transthyretin-Related, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis, Asthma, Bacterial Infections, Bleeding, CML, Cardiac Repolarization in Healthy Subjects, Chronic Hepatitis B, Chronic Kidney Diseases

Studies at this site

• GATEWAY: A Phase 2a Study of PORT-77 in Adults With Erythropoietic Protoporphyria — Completed
• Study to Evaluate Safety and Activity of TRL345 in Healthy Volunteers — Completed
• A Study of TAK-881 and HyQvia in Healthy Adults — Completed
• Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study of PORT-77 Administered to Healthy Adult Participants — Completed
• Staccato® Granisetron Single Dose PK — Completed
• A Drug-Drug Interaction Study of Denifanstat and Resmetirom in Healthy Adult Participants — Completed
• A First-In-Human Study of TAK-004 in Healthy Adults — Completed
• A Study of Effects of Selpercatinib (LY3527723) on Repaglinide in Healthy Participants — Completed
• A Single-dose Study to Investigate the Effect of Injection Site on KAI-9531 Relative Bioavailability in a Range of Body Mass Indices — Completed
• A Study to Investigate the Safety, Tolerability, and Drug Levels of BMS-986419 (Part 1) and the Effects Multiple Doses of BMS-986419 on Cardiac Repolarization (Part 2) in Healthy Participants — Completed
• Drug-Drug Interaction Study of Casdatifan in Healthy Adult Participants (ARC-29) — Completed
• A Dose Calibration Study Comparing IkT-001Pro to Imatinib Mesylate 400mg — Completed
• A Study of TAK-881 With and Without Ramp-Up Dosing in Healthy Adults — Completed
• A Study of Effects of Selpercatinib (LY3527723) on Midazolam in Healthy Participants — Completed
• A Cardiac Liability Study of Varegacestat in Healthy Participants — Completed
• A Study of Effects of Itraconazole and Rifampin on Selpercatinib (LY3527723) in Healthy Participants — Completed
• A Study of Effect of Food and a Proton Pump Inhibitor on Selpercatinib (LY3527723) in Healthy Participants — Completed
• A Study of Effect of Selpercatinib (LY3527723) on Corrected QT (QTc) Interval in Healthy Participants — Completed
• A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants Receiving a Glucagon-like Peptide-1 (GLP-1) Agonist — Completed
• A Study of Selpercatinib (LY3527723) in Healthy Participants — Completed
• A Phase 1 Study to Examine the Effects of Itraconazole After Single Dose Administration of Varegacestat (AL102) to Healthy Participants — Completed
• A Single and Multiple Ascending Dose Study of CK-4021586 in Healthy Adult Participants — Completed
• A Study to Assess the Bioequivalence of Ustekinumab by Two Different Injection Devices in Healthy Participants — Completed
• A Study to Evaluate Effect of Verapamil and Food of Sevasemten in Healthy Volunteers — Completed
• A Study of Interaction of Zasocitinib (TAK-279) With Other Medicines in Healthy Adults — Completed
• A Study of Macitentan and Tadalafil as a Fixed Dose Combination and the Free Combination in Healthy Adult Participants — Completed
• A Study of Single and Multiple Doses of Different Formulations of a Prostacyclin Receptor Agonist — Completed
• A Study to Investigate the Effect of Different Particle Sizes on the Single-dose Pharmacokinetics of Rilpivirine After Intramuscular Injection of a Long-acting Nanosuspension in Healthy Participants — Completed
• A Study of Subcutaneously-administered Guselkumab Delivered by 3 Different Devices in Healthy Participants — Completed
• A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-54767414 (Daratumumab) in Healthy Participants — Completed
• A Study of Maribavir Pediatric Formulation in Healthy Adult Participants — Completed
• Study of Single Doses of SBT115301 in Healthy Participants — Completed
• Relative Bioavailability and Food Effect Study of CVN424 — Completed
• Single and Multiple Ascending Dose Study Assessing the Safety, Tolerability, PK and PD of AG10 — Completed
• A Study of TAK-105 in Healthy Adults — Completed
• A Study of EDG-7500 in Healthy Adults — Completed
• A Study of TAK-279 in Healthy Adults on the Effect on ECG Measurements — Completed
• Study of Potential CYP3A4 Induction by INDV-2000 in Healthy Adults — Completed
• A Study of the Interaction of Other Drugs With TAK-279 in Healthy Adults — Completed
• A Study of Soticlestat Tablets in Healthy Adults — Completed
• Effect of Repeated Oral Doses of Avacopan on the Pharmacokinetics (PK) of a Single Dose of Simvastatin — Completed
• A Study of Relative Bioavailability of a New Formulation Compared With the Approved Formulation of rhPTH [1-84] and to Find Out Dose Linearity of the New Formulation in Healthy Adults — Completed
• Study of the Safety, Tolerability, and PK of MRX-8 Administered Intravenously to HVs in SAD and MAD Cohorts — Completed
• A Study in Healthy Volunteers to Evaluate the Drug-Drug Interaction Potential of CCX168 With Concomitant Medications — Completed
• A Study in Healthy Volunteers to Evaluate the Pharmacokinetic Food Effect and Cardiac Safety of CCX168 — Completed
• A Study to Assess the Effect of Avacopan at Therapeutic and Supratherapeutic Doses on the QT/QTc Interval in Healthy Participants — Completed
• A Study in Older Subjects to Evaluate the Safety and Ability of Andexanet Alfa to Reverse the Anticoagulation Effect of Apixaban — Completed
• An Inpatient Study of ALLN-346 (Engineered Urate Oxidase) in Hyperuricemic Subjects (Study 201) — Completed
• A Study of Four Different Oral Tablet Formulations of Lazertinib (JNJ-73841937) in Healthy Adult Participants — Completed
• Drug Interaction Study of MGL-3196 With Rosuvastatin and Simvastatin — Completed